Canopy Growth Corporation

TSX:WEED.TO

Drug Manufacturers - Specialty & Generic

Healthcare
$0.72 +2.26%

+$0.03 today

Market cap
$323.72M
Beta
2.41
P/E (TTM)
-1.8
EPS (TTM)
-$0.76
52W Low $1.18High $3.28

Volume 1.16M

Average 2.07M

WEED.TO Interest Expense

Cost of servicing the company's debt during the period.

Canopy Growth CorporationTSX: WEED.TO

Interest Expense · Q4 FY2025 · quarter ended Mar 2026

Interest expense declines year over year

Q4 FY2025 interest expense of CA$12.31M fell 20.0% year over year, ahead of the -44.1% change in trailing-twelve-month interest expense. Sequentially, it rose 67.8% from the prior quarter. Over 3 fiscal years it compounded at -32.9% a year.

Context

  • Interest expense amounted to 13.4% of revenue in FY2025, down 14.3 pp from a year earlier.
  • Interest expense increased in 0 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of -20.0% holds above the trailing-twelve-month pace of -44.1%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
CA$12.31M+67.8% QoQ
Last fiscal yearMar 2026
CA$38.19M-48.8% YoY
LTMMar 2026
CA$41.67M-44.1% YoY
Interest Expense past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-20.0%——
1 year-48.8%——
3-year CAGR-32.9%——
5-year CAGR——
10-year CAGR——

Interest Expense history

CAD · from the income statement

Latest · FY2025
38.19M CAD
Year-over-year change
-48.8%
4-year CAGR
-22.1%

Interest Expense vs competitors

How WEED.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so interest expense is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -44.1% is the 4th highest of 8, against a peer median of -45.7%.
  • Interest expense amounts to 13.4% of revenue for WEED.TO, versus a peer median of 3.0%.
WEED.TO Competitors
Interest Expense for WEED.TO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
WEED.TOCanopy Growth CorporationLTM Mar 2026CA$41.67M CAD-44.1%-32.9%13.4%
TSND.TOTerrAscend Corp.LTM Mar 2026$37.61M USD+7.6%-0.9%14.4%
ACB.TOAurora Cannabis Inc.LTM Mar 2026CA$5.82M CAD-30.8%-64.2%1.8%
EDT.TOSpectral Medical Inc.LTM Mar 2026CA$5.68M CAD+52.7%+208.4%205.8%
XLY.TOAuxly Cannabis Group Inc.LTM Mar 2026CA$5.29M CAD-45.7%-33.5%3.3%
FRX.TOFennec Pharmaceuticals Inc.LTM Mar 2026$1.53M USD-57.9%+30.7%3.0%
CPH.TOCipher Pharmaceuticals Inc.LTM Mar 2026$505.84K USD-61.3%—1.0%
OGI.TOOrganiGram Holdings Inc.LTM Mar 2026CA$0 CAD-100.0%—0.0%
Peer median (excluding WEED.TO) —-45.7%-0.9%3.0%

Competitors are the stored peer set for WEED.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2021
Mar 2022
FY2022
Mar 2023
FY2023
Mar 2024
FY2024
Mar 2025
FY2025
Mar 2026
Revenue475.7M333.25M297.15M269M284.6M
Cost of Revenue653.93M431.64M216.26M189.48M214.93M
Gross Profit(143.6M)(98.38M)80.88M79.51M69.67M
Gross Margin-30.2%-29.5%27.2%29.6%24.5%
Research & Development32.26M21.72M4.61M2.74M0
Selling, General & Admin361.1M297.98M175.98M121.71M122.93M
Operating Expenses445.08M297.4M309.6M196.65M142.78M
Depreciation & Amortization110.94M80.03M53.18M43.12M36.47M
EBITDA(52.98M)(2.88B)(312.83M)(479.31M)(188.22M)
EBITDA Margin-11.1%-864.2%-105.3%-178.2%-66.1%
Operating Income(588.69M)(395.78M)(228.71M)(117.14M)(73.11M)
Operating Margin-123.8%-118.8%-77.0%-43.5%-25.7%
Interest Income6.6M24.28M16.24M8.82M10M
Interest Expense103.94M126.16M105.35M74.57M38.19M
Other Income / Expenses370.63M(2.69B)(242.64M)(479.85M)(189.78M)
Income Before Tax(267.86M)(3.09B)(471.36M)(597M)(262.89M)
Pre-Tax Margin-56.3%-926.1%-158.6%-221.9%-92.4%
Income Tax Expense(8.95M)(5.73M)12.33M7.14M23K
Net Income(310.04M)(3.28B)(657.27M)(598.12M)(262.91M)
Net Margin-65.2%-983.7%-221.2%-222.4%-92.4%
EPS (Basic)(0.81)(12.18)(8.79)(5.56)(0.76)
EPS (Diluted)(0.81)(12.18)(8.79)(5.56)(0.76)
Weighted Avg Shares396.1M271.61M74.79M107.55M345.53M
Weighted Avg Shares (Diluted)396.36M271.61M74.79M107.55M345.53M

Canopy Growth Corporation

TSX:WEED.TO

Intrinsic Alpha fair value

Locked

Current Price

$0.72

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.